Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 1/20 | 0.67 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.67 |
| ▸ | ACHE | P22303 | 4/20 | 0.41 |
| ▸ | BCHE | P06276 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | HTR6 | P50406 | 1/20 | 0.36 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL5345726 | 0.98 | APOBEC3A (0.64) | APOBEC3AAPOBEC3GACHEBCHECA12 | |
| SCHEMBL330485 | 0.93 | APOBEC3A (0.64) | APOBEC3AAPOBEC3GACHEBCHECA12 | |
| Sulfuric Acid SCHEMBL5345728 | 0.91 | APOBEC3A (0.61) | APOBEC3AAPOBEC3GACHEBCHECA12 | |
| SCHEMBL331179 | 0.89 | APOBEC3A (0.58) | APOBEC3AAPOBEC3GACHEBCHECA12 | |
| SCHEMBL2531547 | 0.87 | APOBEC3A (0.56) | APOBEC3AAPOBEC3GACHEBCHEALDH1A1 | |
| SCHEMBL330822 | 0.87 | APOBEC3G (0.56) | APOBEC3AAPOBEC3GACHEBCHECA12 | |
| Sulfuric Acid SCHEMBL27613503 | 0.87 | APOBEC3A (0.56) | APOBEC3AAPOBEC3GACHEBCHECA12 | |
| Sulfuric Acid SCHEMBL2386168 | 0.85 | APOBEC3A (0.67) | APOBEC3AAPOBEC3GACHEBCHECA2 | |
| Trifluoromethanesulfonic Acid SCHEMBL17477312 | 0.85 | APOBEC3A (0.54) | APOBEC3AAPOBEC3GACHEBCHECA2 | |
| SCHEMBL2385111 | 0.84 | APOBEC3A (0.82) | APOBEC3AAPOBEC3GACHEBCHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | NOVUS INTERNATIONAL INC. (US) | 2011-09-15 | — | — | US | claimed |
| CN-118984809-A | CHA type zeolite and method for synthesizing the same | 庄信万丰股份有限公司 | 2024-11-19 | — | — | CN | disclosed |
| US-10435566-B2 | Particles for electrophoretic displays | MERCK PATENT GMBH (DE) | 2019-10-08 | — | — | US | disclosed |
| EP-3233944-B1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | MERCK PATENT GMBH (DE) | 2019-09-04 | — | — | EP | disclosed |
| US-20180037744-A1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | E INK CORPORATION | 2018-02-08 | — | — | US | disclosed |
| EP-3233944-A1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | Merck Patent GmbH (DE) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016096091-A1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | MERCK PATENT GMBH (DE) | 2016-06-23 | — | — | WO | disclosed |
| US-8742170-B2 | Preparation of methionine or selenomethionine from homoserine via a 4-substituted 2-aminobutanoic acid intermediate | NOVUS INTERNATIONAL, INC. (US) | 2014-06-03 | — | — | US | disclosed |
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | NOVUS INTERNATIONAL INC. (US) | 2011-09-15 | — | — | US | disclosed |
| WO-2010118274-A1 | PREPARATION OF 6-KETO, 3-ALKOXY MORPHINANS | MALLINCKRODT INC. (US) | 2010-10-14 | — | — | WO | disclosed |
| US-20100261906-A1 | Preparation of 6-Keto, 3-Alkoxy Morphinans | MALLINCKRODT INC. (US) | 2010-10-14 | — | — | US | disclosed |
| US-20020103328-A1 | Aromatic polycarbonate composition, production process therefor and molded product thereof | TEIJIN LIMITED | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180037744-A1 | PARTICLES FOR ELECTROPHORETIC DISPLAYS | RAB5IF, GYPA, SELP | APOBEC3A 1747/4885APOBEC3G 1237/4885ACHE 3101/4885 |
| US-10435566-B2 | Particles for electrophoretic displays | RAB5IF, SELP, SELE | APOBEC3A 1787/4885APOBEC3G 1229/4885ACHE 3606/4885 |
| US-20100261906-A1 | Preparation of 6-Keto, 3-Alkoxy Morphinans | FASN, CYP2D6, CYP2B6 | APOBEC3A 438/4885APOBEC3G 331/4885ACHE 935/4885 |
| US-20110224458-A1 | PREPARATION OF METHIONINE OR SELENOMETHIONINE FROM HOMOSERINE VIA A 4-SUBSTITUTED 2-AMINOBUTANOIC ACID INTERMEDIATE | MTR, CBS, ABAT | APOBEC3A 3356/4885APOBEC3G 3619/4885ACHE 4455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.